Crossmark

Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis: Subgroup analysis of Latin American patients in the phase 3 randomized UNCOVER-3 study

Crossref DOI link: https://doi.org/10.1016/j.ad.2017.02.005

Published Print: 2017-07

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Valenzuela, F.

de la Cruz Fernandez, C.

Galimberti, R.L.

Gürbüz, S.

McKean-Matthews, M.

Goncalves, L.

Romiti, R.
License Information

Text and Data Mining valid from 2017-07-01
More Information

This article is maintained by: Elsevier

Article Title: Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis: Subgroup analysis of Latin American patients in the phase 3 randomized UNCOVER-3 study

Journal Title: Actas Dermo-Sifiliográficas

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.ad.2017.02.005

Content Type: article

Copyright: © 2017 AEDV. Published by Elsevier España, S.L.U. All rights reserved.

Document is current

Any future updates will be listed below